Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain
出版年份 2019 全文链接
标题
Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume 38, Issue 6, Pages 1105-1111
出版商
Springer Science and Business Media LLC
发表日期
2019-04-16
DOI
10.1007/s10096-019-03503-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
- (2018) L Clifford McDonald et al. CLINICAL INFECTIOUS DISEASES
- Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States
- (2018) Dongmu Zhang et al. CLINICAL INFECTIOUS DISEASES
- Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness
- (2018) Oliver A Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial
- (2018) Benoit Guery et al. LANCET INFECTIOUS DISEASES
- Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life
- (2017) Mark H. Wilcox et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of Clostridium difficile recurrence on hospital readmissions
- (2015) Margaret A. Olsen et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain
- (2015) C. Rubio-Terrés et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Efficacy of alternative fidaxomicin dosing regimens for treatment of simulatedClostridium difficileinfection in anin vitrohuman gut model
- (2015) C. H. Chilton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Attributable Inpatient Costs of Recurrent Clostridium difficile Infections
- (2014) Erik R. Dubberke et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach
- (2014) E. van Kleef et al. JOURNAL OF HOSPITAL INFECTION
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Efecto de la infección por Clostridium difficile sobre la estancia hospitalaria. Estudio de cohortes
- (2013) Diana Monge et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Fidaxomicin: A novel macrocyclic antibiotic for the treatment of Clostridium difficile infection
- (2012) T. Crawford et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
- (2012) T. J. Louie et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
- (2012) Derrick W. Crook et al. CLINICAL INFECTIOUS DISEASES
- The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem?
- (2012) L. Alcalá et al. CLINICAL MICROBIOLOGY AND INFECTION
- Can we identify patients at high risk of recurrent Clostridium difficile infection?
- (2012) C.P. Kelly CLINICAL MICROBIOLOGY AND INFECTION
- Epidemiology, diagnosis and treatment ofClostridium difficileinfection
- (2012) Matteo Bassetti et al. Expert Review of Anti-Infective Therapy
- Fidaxomicin: a new option for the treatment of Clostridium difficile infection
- (2012) A. P. Johnson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
- (2012) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance
- (2012) Robert A. Britton et al. TRENDS IN MICROBIOLOGY
- Laboratory diagnosis of Clostridium difficile infection in Spain: a population-based survey
- (2011) L. Alcalá et al. JOURNAL OF HOSPITAL INFECTION
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-dose versus multiple-dose antibiotic prophylaxis for the surgical treatment of closed fractures
- (2010) Gerard P Slobogean et al. Acta Orthopaedica
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started